Company Profiles

driven by the PitchBook Platform

Apsara Therapeutics

Description

Developer of antibody therapies. The company develops Neuromyelitis Optica (NMO) that block the initiating events in NMO pathogenesis. It operates as a biotechnology company.

PRIVATE

Status

Early Stage VC

Latest Deal Type

$1M

Latest Deal Amount

$2M

Total Amount Raised

1

Investors

Description

Developer of antibody therapies. The company develops Neuromyelitis Optica (NMO) that block the initiating events in NMO pathogenesis. It operates as a biotechnology company.

Website:

www.apsaratherapeutics.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Primary Office

One Greenway Plaza Suite 930 Houston, TX 77046United States +1 (949) 682-9204
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Apsara Therapeutics's full profile, request a free trial.

    Apsara Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Apsara Therapeutics Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Mercury FundVenture CapitalMinority000 0000000 0000
    Mercury Fund Venture Capital

    Apsara Therapeutics Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Daniel Janiak Ph.DCo-Founder & Board Member
    Daniel Janiak Ph.D Co-Founder & Board Member

    Apsara Therapeutics Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Daniel Janiak Ph.DSelfCo-Founder & Board Member000 0000
    Daniel Watkins Ph.DMercury FundPartner000 0000
    Daniel Janiak Ph.D Co-Founder & Board Member Self
    Daniel Watkins Ph.D Partner Mercury Fund
    Request full access to PitchBook